Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AJANTPHARM | NSE
58.60
2.01%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/03/2026
2,974.90
2,905.00
2,988.90
2,900.10
Ajanta Pharma Limited a specialty pharmaceutical formulation company together with its subsidiaries develops manufactures and markets finished dosages. The company markets and serves various therapeutic segments such as anti-biotic anti-malarial diabetic cardiology gynecology respiratory and general health products dermatology and pain management areas. It also provides tablets capsules powder liquid jelly ointments eye drops active pharma ingredient. The company serves in India Africa rest of Asia the United States and internationally. The company was founded in 1973 and is headquartered in Mumbai India.
View LessStrength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
23.2%1 month
21.4%3 months
23.9%6 months
21.6%47.17
-
11.33
0.01
0.01
30.61
9.36
-
12.23B
376.80B
4.10B
1.13
25.89
18.10
12.10
23.47
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
224.00
Range1M
283.40
Range3M
508.20
Rel. volume
1.05
Price X volume
331.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ipca Laboratories Limited | IPCALAB | Drug Manufacturers-Specialty & Generic | 1500.9 | 380.78B | 1.73% | 72.46 | 22.72% |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | Drug Manufacturers-Specialty & Generic | 2070.4 | 321.56B | 0.91% | 51.20 | 12.92% |
| Dr. Reddy's Laboratories Limited | DRREDDY | Drug Manufacturers-Specialty & Generic | 1313.5 | 218.82B | 1.73% | 20.23 | 10.41% |
| AstraZeneca Pharma India Limited | ASTRAZEN | Drug Manufacturers-Specialty & Generic | 8601 | 215.02B | -1.15% | 197.18 | 0.65% |
| Wockhardt Limited | WOCKPHARMA | Drug Manufacturers-Specialty & Generic | 1305.2 | 200.25B | 1.15% | n/a | 70.14% |
| Eris Lifesciences Limited | ERIS | Drug Manufacturers-Specialty & Generic | 1370.2 | 186.76B | 0.89% | 48.08 | 107.55% |
| Neuland Laboratories Limited | NEULANDLAB | Drug Manufacturers-Specialty & Generic | 12926 | 181.50B | 1.17% | 53.76 | 7.44% |
| NATCO Pharma Limited | NATCOPHARM | Drug Manufacturers-Specialty & Generic | 1000.8 | 179.25B | 5.00% | 15.31 | 6.34% |
| Alembic Pharmaceuticals Limited | APLLTD | Drug Manufacturers-Specialty & Generic | 707.5 | 141.77B | 1.32% | 36.23 | 10.65% |
| Granules India Limited | GRANULES | Drug Manufacturers-Specialty & Generic | 573.3 | 138.95B | 3.42% | 29.41 | 40.77% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| AFFLE | AFFLE | Advertising Agencies | 1359.5 | 190.13B | -3.16% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 387.7 | 94.83B | 4.36% | 84.26 | 27.74% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 1957.7 | 69.84B | 1.56% | 120.49 | 191.28% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 41.65 | 36.54B | -2.85% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 107.41 | 15.83B | -0.11% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 232.55 | 13.63B | -1.77% | 30.54 | 80.30% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 161.41 | 5.21B | -1.23% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 69.96 | 1.93B | -0.06% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 95.5 | 1.39B | -1.90% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 72.51 | 808.40M | -0.45% | 50.06 | 4.88% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 30.61 | 24.85 | Expensive |
| Ent. to Revenue | 9.36 | 11.40 | Par |
| PE Ratio | 47.17 | 51.36 | Par |
| Price to Book | 11.33 | 6.83 | Expensive |
| Dividend Yield | 1.13 | 0.52 | Leader |
| Std. Deviation (3M) | 23.89 | 42.17 | Lower Risk |
| Debt to Equity | 0.01 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 376.80B | 290.82B | Market Leader |